TrialBlood cancer journal2020

Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT).

Brian G M Durie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.